Postherpetic Neuralgia: A Patient’s and a Physician’s Perspective
- Today, most experts in interventional pain management recommend an evidence-based stepladder approach for the management of all patients with PHN that includes an advancing combination of therapeutic strategies as needed on a graduated basis to control pain and anxiety and prevent complications, including suicide.
- The most important immunologic risk factor for herpes zoster and PHN is the decline in cell-mediated immunity to VZV that occurs over time as people age, with an onset around 50 years of age. Although possible, second episodes of zoster are uncommon due to the boosting or anamnestic effect of the first episode of zoster.
- The nonpharmacologic treatment options for PHN include combinations of acupuncture, cryotherapy, heat therapy, and transcutaneous and/or percutaneous electrical nerve stimulation. The multimodal nonpharmacologic treatment options for PHN are stratified and compared by their evidence levels.